Viral Infections

Total Page:16

File Type:pdf, Size:1020Kb

Viral Infections 25/12/2018 Introduction to Microbiology for M.D. Students University of Jordan School of Medicine Department of Pathology, Microbiology and Forensic Medicine Section of Microbiology and Immunology Malik Sallam, MD, PhD What are viruses? 1 25/12/2018 General Characteristics of Viruses • Obligate intracellular parasites. • Extremely small size. • Genome is either DNA or RNA (never both). • Extremely variable. • Uncertain origin. Terminology 2 25/12/2018 Virus Taxonomy-ICTV Classification Order (-virales) Family (-viridae) Subfamily (-virinae) Genus (-virus) Species Baltimore Classification 3 25/12/2018 Virus Classification • Morphology (capsid symmetry, presence of an envelope, etc.). • Host organism (human, animal, plant, bacteria). • Type of disease (hepatitis viruses, respiratory viruses, etc.). Virus Classification 4 25/12/2018 Virus Classification Overview of Human Viruses-DNA Viruses • HHAPPPy viruses: Herpesviridae oReplicate in the nucleus (except Pox). Hepadnaviridae oDouble-stranded (except Parvo). Adenoviridae oNaked vs. Enveloped. Papovaviridae Parvoviridae Poxviridae 5 25/12/2018 Overview of Human Viruses-RNA Viruses Arenaviridae Picornaviridae Bunyaviridae Reoviridae Caliciviridae Retroviridae Coronaviridae Rhabdoviridae Filoviridae Togaviridae Orthomyxoviridae Paramyxoviridae Herpesviruses: An Overview o The outstanding property of herpesviruses is their ability to establish lifelong persistent infections in their hosts and to undergo periodic reactivation. o Their frequent reactivation in immunosuppressed patients causes serious health complications. 6 25/12/2018 Herpesviruses: An Overview o Double-stranded DNA virus. o Icosahedral symmetry. o Enveloped. o Envelope is acquired from the nuclear membrane. o Baltimore Class I. Herpes Simplex Viruses-Introduction o Hippocrates used the Greek word herpes to describe lesions that seem to creep or crawl along the skin. o ICTV designate the two species as human herpesviruses 1 and 2 (HHV-1) and (HHV-2). o The two species were first identified as two distinct serotypes; herpes simplex viruses 1 and 2 (HSV-1) and (HSV-2). 7 25/12/2018 Herpes Simplex Viruses Taxonomy Order (Herpesvirales) Family (Herpesviridae) Subfamily (Alphaherpesvirinae) Genus (Simplexvirus) Species (Human herpesvirus 1; HHV-1) Species (Human herpesvirus 2; HHV-2) Herpes Simplex Viruses-Important Features Natural Host: Human, mammals. Tropism: Epithelial mucosal cells. Latency: Sensory neurons (dorsal ganglia). Cellular receptors: Heparan sulfate among others. Geography: Worldwide. 8 25/12/2018 Herpes Simplex Viruses-Important Features o Transmission (HHV-1): Direct contact, saliva. o Transmission (HHV-2): Sexual contact, vertical. o HSV is transmitted by contact with an individual excreting virus. o The virus must encounter mucosal surfaces or broken skin in order for an infection to be initiated (unbroken skin is resistant). Herpes Simplex Viruses-Characteristic Lesions Vesicles are circumscribed epidermal elevations containing clear fluid and less than 1 cm in diameter. If the lesion has a diameter of greater than 1 cm, it is called a bulla. Vesicles and bullae are commonly called blisters. 9 25/12/2018 Herpes Simplex Viruses-Pathogenesis & Pathology . Primary infection o Viral replication occurs first at the site of infection. o HSV then invades local nerve endings and is transported by retrograde axonal flow to dorsal root ganglia. o After further replication, latency is established. o Oropharyngeal infections result in latent infections in the trigeminal ganglia. o Genital infections lead to latently infected sacral ganglia. Herpes Simplex Viruses-Pathogenesis & Pathology . Primary infection o Primary HSV infections are usually asymptomatic. o Most symptomatic primary infections are mild. o Only rarely does systemic disease develop. o Widespread organ involvement can result when an immunocompromised host is not able to limit viral replication and viremia ensues. 10 25/12/2018 Herpes Simplex Viruses-Pathogenesis & Pathology . Latent infection o Virus resides in latently infected ganglia with very few viral genes being expressed. Herpes Simplex Viruses-Pathogenesis & Pathology . Latent infection o Provocative stimuli can reactivate virus from the latent state, including: Axonal injury. Fever. Physical or emotional stress. Exposure to ultraviolet light. 11 25/12/2018 Herpes Simplex Viruses-Pathogenesis & Pathology . Latent infection o The virus follows axons back to the peripheral site, and replication proceeds at the skin or mucous membranes. o HSV-specific immunity limits local viral replication, so that recurrent infections are less extensive and less severe. o Many recurrences are asymptomatic, reflected only by viral shedding in secretions. Primary/Recurrent Oropharyngeal Disease . Gingivostomatitis. Pharyngitis. Mononucleosis-like syndrome. Herpes labialis (cold sores). 12 25/12/2018 Primary/Recurrent Oropharyngeal Disease . The incubation period ranges from 2-12 days, with a mean of 4 days. The duration of clinical illness may be from 2-3 weeks. Primary/Recurrent Genital Disease . Genital herpes: o Symptomatic primary genital infection is the most severe, lasting about 3 weeks. 13 25/12/2018 Primary/Recurrent Genital Disease . Genital herpes o In females: Excruciatingly painful lesions in the vulva, perineum, buttocks, cervix, and/or vagina associated with inguinal adenopathy and dysuria. o In males: Lesions involving the glans penis or the penile shaft with extragenital lesions of the thigh, buttocks, and perineum. o Proctitis can occur in male homosexuals. o Recurrences of genital herpetic infections are common and tend to be mild. Primary/Recurrent Genital Disease . Genital herpes o Recent evidence documented the increase in the frequency of genital (HSV‐1) compared with genital (HSV‐2) infection. This trend has been seen both in Europe, Australia and in the US. o Oral shedding of HSV-2 is infrequent. 14 25/12/2018 Neonatal Herpes Simplex Virus Infection • The estimated incidence of neonatal HSV infection is 1 in 3,000 to 1 in 5,000 deliveries per year. • May be acquired in utero, during birth, or after birth. • Neonatal herpes infections are almost always symptomatic. • The overall mortality rate of untreated disease is 50%. • Many survivors of severe infections are left with permanent neurologic impairment. Herpes Simplex Keratoconjunctivitis HHV-1 infections may occur in the eye, producing severe keratoconjunctivitis. Recurrent lesions of the eye are common and appear as dendritic keratitis or corneal ulcers or as vesicles on the eyelids. Keratitis may end up in blindness. Pathognomonic Dendritic Ulceration 15 25/12/2018 Herpetic Skin Infections o Usually manifest as eczema herpeticum in patients with underlying atopic dermatitis. o Disseminated HSV infections have been also reported among wrestlers (herpes gladiatorum). Herpetic Skin Infections o Rarely, the infection may be spread to the distal phalanx via direct inoculation and cause pain, swelling, erythema, and vesicles in an entity known as herpetic whitlow. 16 25/12/2018 Infections of the Immunocompromised Host o Immunocompromised patients are at increased risk of developing severe HSV infections. o These include patients immunosuppressed by disease or therapy. o Patients with deficient cellular immunity suffer more frequent and more severe HSV infections. o Herpes lesions may spread and involve the respiratory tract, esophagus, and intestinal mucosa. o In most cases, the disease reflects reactivation of latent HSV infection. Infections of the Central Nervous System o HSV encephalitis is one of the most devastating of all HSV infection. o HSV-1 (HHV-1) is considered the most common cause of sporadic, fatal encephalitis. o The disease carries a high mortality rate. o Aseptic meningitis is a common occurrence in individuals with primary genital HSV infections. 17 25/12/2018 Diagnosis o Clinical diagnosis. o Virus isolation is a definitive diagnostic method (samples include: skin scrapings, throat swab, CSF). o PCR detection of viral DNA. o Cytopathology with Giemsa stain of scrapings (Tzanck smear). o Serology. Treatment o Nucleoside analogues: acyclovir, valacyclovir, penciclovir and famciclovir. o All nucleoside and nucleotide analogues must be activated by phosphorylation usually to the triphosphate form to exert their action. o Mechanism of action: Inhibition of viral genome replication through inhibiting the viral polymerase. 18 25/12/2018 Treatment o The virus thymidine kinase is much more potent compared to the cellular kinases in activating the drug, ∴ it is more efficient in virus- infected cells. o Treatment is important in herpes encephalitis, neonatal herpes, and disseminated infections in immunocompromised patients. o Despite treatment, HSV remains latent in sensory ganglia. o Drug-resistant virus strains may emerge. Epidemiology In 2012, an estimated 3.7 billion people under the age of 50, or 67% of the world population, had HSV-1 infection (WHO). The overall prevalence of HSV-2 among 15–49 year olds world-wide in 2012 is estimated to be 11% (over 400 million people). 19 25/12/2018 Prevention and Control o Educational efforts must be developed for adolescents and those at greatest risk. o Surgical abdominal delivery. o Hospital staff: Temporary removal of personnel who have cold sores is advocated for clinical services. o Experimental vaccines. Varicella Zoster Virus (VZV)-Introduction o Zoster was derived from a Greek word meaning belt. o Shingles was derived from a Latin word meaning
Recommended publications
  • Trunkloads of Viruses
    COMMENTARY Trunkloads of Viruses Philip E. Pellett Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan, USA Elephant populations are under intense pressure internationally from habitat destruction and poaching for ivory and meat. They also face pressure from infectious agents, including elephant endotheliotropic herpesvirus 1 (EEHV1), which kills ϳ20% of Asian elephants (Elephas maximus) born in zoos and causes disease in the wild. EEHV1 is one of at least six distinct EEHV in a phylogenetic lineage that appears to represent an ancient but newly recognized subfamily (the Deltaherpesvirinae) in the family Herpesviridae. lephant endotheliotropic herpesvirus 1 (EEHV1) causes a rap- the Herpesviridae (the current complete list of approved virus tax- Downloaded from Eidly progressing and usually fatal hemorrhagic disease that ons is available at http://ictvonline.org/). In addition, approxi- occurs in the wild in Asia and affects ϳ20% of Asian elephant mately 200 additional viruses detected using methods such as (Elephas maximus) calves born in zoos in the United States and those described above await formal consideration (V. Lacoste, Europe (1). About 60% of juvenile deaths of captive elephants are personal communication). With very few exceptions, the amino attributed to such infections. Development of control measures acid sequence of a small conserved segment of the viral DNA poly- has been hampered by the lack of systems for culture of the virus in merase (ϳ150 amino acids) is sufficient to not only reliably iden- laboratories. Its genetic study has been restricted to analysis of tify a virus as belonging to the evolutionary lineage represented by blood, trunk wash fluid, and tissue samples collected during nec- the Herpesviridae, but also their subfamily, and in most cases a http://jvi.asm.org/ ropsies.
    [Show full text]
  • Ostreid Herpesvirus Type 1 Replication and Host Response in Adult Pacific
    Segarra et al. Veterinary Research 2014, 45:103 http://www.veterinaryresearch.org/content/45/1/103 VETERINARY RESEARCH RESEARCH Open Access Ostreid herpesvirus type 1 replication and host response in adult Pacific oysters, Crassostrea gigas Amélie Segarra1, Laury Baillon1, Delphine Tourbiez1, Abdellah Benabdelmouna1, Nicole Faury1, Nathalie Bourgougnon2 and Tristan Renault1* Abstract Since 2008, massive mortality outbreaks associated with OsHV-1 detection have been reported in Crassostrea gigas spat and juveniles in several countries. Nevertheless, adult oysters do not demonstrate mortality in the field related to OsHV-1 detection and were thus assumed to be more resistant to viral infection. Determining how virus and adult oyster interact is a major goal in understanding why mortality events are not reported among adult Pacific oysters. Dual transcriptomics of virus-host interactions were explored by real-time PCR in adult oysters after a virus injection. Thirty-nine viral genes and five host genes including MyD88, IFI44, IkB2, IAP and Gly were measured at 0.5, 10, 26, 72 and 144 hours post infection (hpi). No viral RNA among the 39 genes was detected at 144 hpi suggesting the adult oysters are able to inhibit viral replication. Moreover, the IAP gene (oyster gene) shows significant up-regulation in infected adults compared to control adults. This result suggests that over-expression of IAP could be a reaction to OsHV-1 infection, which may induce the apoptotic process. Apoptosis could be a main mechanism involved in disease resistance in adults. Antiviral activity of haemolymph againstherpessimplexvirus(HSV-1)wasnotsignificantly different between infected adults versus control. Introduction infection of C.
    [Show full text]
  • Comparative Analysis, Distribution, and Characterization of Microsatellites in Orf Virus Genome
    www.nature.com/scientificreports OPEN Comparative analysis, distribution, and characterization of microsatellites in Orf virus genome Basanta Pravas Sahu1, Prativa Majee 1, Ravi Raj Singh1, Anjan Sahoo2 & Debasis Nayak 1* Genome-wide in-silico identifcation of microsatellites or simple sequence repeats (SSRs) in the Orf virus (ORFV), the causative agent of contagious ecthyma has been carried out to investigate the type, distribution and its potential role in the genome evolution. We have investigated eleven ORFV strains, which resulted in the presence of 1,036–1,181 microsatellites per strain. The further screening revealed the presence of 83–107 compound SSRs (cSSRs) per genome. Our analysis indicates the dinucleotide (76.9%) repeats to be the most abundant, followed by trinucleotide (17.7%), mononucleotide (4.9%), tetranucleotide (0.4%) and hexanucleotide (0.2%) repeats. The Relative Abundance (RA) and Relative Density (RD) of these SSRs varied between 7.6–8.4 and 53.0–59.5 bp/ kb, respectively. While in the case of cSSRs, the RA and RD ranged from 0.6–0.8 and 12.1–17.0 bp/kb, respectively. Regression analysis of all parameters like the incident of SSRs, RA, and RD signifcantly correlated with the GC content. But in a case of genome size, except incident SSRs, all other parameters were non-signifcantly correlated. Nearly all cSSRs were composed of two microsatellites, which showed no biasedness to a particular motif. Motif duplication pattern, such as, (C)-x-(C), (TG)- x-(TG), (AT)-x-(AT), (TC)- x-(TC) and self-complementary motifs, such as (GC)-x-(CG), (TC)-x-(AG), (GT)-x-(CA) and (TC)-x-(AG) were observed in the cSSRs.
    [Show full text]
  • Virus–Host Interactions and Their Roles in Coral Reef Health and Disease
    !"#$"%& Virus–host interactions and their roles in coral reef health and disease Rebecca Vega Thurber1, Jérôme P. Payet1,2, Andrew R. Thurber1,2 and Adrienne M. S. Correa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cycling. Last, we outline how marine viruses are an integral part of the reef system and suggest $4&$($4-(01.,/-1'-(+.(80%/#-#(+1(%--.(./1'$0+1(0#(&1(-##-1$0&,('+>3+1-1$(+.($4-#-(:,+"&,,9( 0>3+%$&1$(-180%+1>-1$#; To p - d ow n e f f e c t s Viruses infect all cellular life, including bacteria and evidence that macroorganisms play important parts in The ecological concept that eukaryotes, and contain ~200 megatonnes of carbon the dynamics of viroplankton; for example, sponges can organismal growth and globally1 — thus, they are integral parts of marine eco- filter and consume viruses6,7.
    [Show full text]
  • Viruses in Transplantation - Not Always Enemies
    Viruses in transplantation - not always enemies Virome and transplantation ECCMID 2018 - Madrid Prof. Laurent Kaiser Head Division of Infectious Diseases Laboratory of Virology Geneva Center for Emerging Viral Diseases University Hospital of Geneva ESCMID eLibrary © by author Conflict of interest None ESCMID eLibrary © by author The human virome: definition? Repertoire of viruses found on the surface of/inside any body fluid/tissue • Eukaryotic DNA and RNA viruses • Prokaryotic DNA and RNA viruses (phages) 25 • The “main” viral community (up to 10 bacteriophages in humans) Haynes M. 2011, Metagenomic of the human body • Endogenous viral elements integrated into host chromosomes (8% of the human genome) • NGS is shaping the definition Rascovan N et al. Annu Rev Microbiol 2016;70:125-41 Popgeorgiev N et al. Intervirology 2013;56:395-412 Norman JM et al. Cell 2015;160:447-60 ESCMID eLibraryFoxman EF et al. Nat Rev Microbiol 2011;9:254-64 © by author Viruses routinely known to cause diseases (non exhaustive) Upper resp./oropharyngeal HSV 1 Influenza CNS Mumps virus Rhinovirus JC virus RSV Eye Herpes viruses Parainfluenza HSV Measles Coronavirus Adenovirus LCM virus Cytomegalovirus Flaviviruses Rabies HHV6 Poliovirus Heart Lower respiratory HTLV-1 Coxsackie B virus Rhinoviruses Parainfluenza virus HIV Coronaviruses Respiratory syncytial virus Parainfluenza virus Adenovirus Respiratory syncytial virus Coronaviruses Gastro-intestinal Influenza virus type A and B Human Bocavirus 1 Adenovirus Hepatitis virus type A, B, C, D, E Those that cause
    [Show full text]
  • Diversity and Evolution of Novel Invertebrate DNA Viruses Revealed by Meta-Transcriptomics
    viruses Article Diversity and Evolution of Novel Invertebrate DNA Viruses Revealed by Meta-Transcriptomics Ashleigh F. Porter 1, Mang Shi 1, John-Sebastian Eden 1,2 , Yong-Zhen Zhang 3,4 and Edward C. Holmes 1,3,* 1 Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life & Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia; [email protected] (A.F.P.); [email protected] (M.S.); [email protected] (J.-S.E.) 2 Centre for Virus Research, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia 3 Shanghai Public Health Clinical Center and School of Public Health, Fudan University, Shanghai 201500, China; [email protected] 4 Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing 102206, China * Correspondence: [email protected]; Tel.: +61-2-9351-5591 Received: 17 October 2019; Accepted: 23 November 2019; Published: 25 November 2019 Abstract: DNA viruses comprise a wide array of genome structures and infect diverse host species. To date, most studies of DNA viruses have focused on those with the strongest disease associations. Accordingly, there has been a marked lack of sampling of DNA viruses from invertebrates. Bulk RNA sequencing has resulted in the discovery of a myriad of novel RNA viruses, and herein we used this methodology to identify actively transcribing DNA viruses in meta-transcriptomic libraries of diverse invertebrate species. Our analysis revealed high levels of phylogenetic diversity in DNA viruses, including 13 species from the Parvoviridae, Circoviridae, and Genomoviridae families of single-stranded DNA virus families, and six double-stranded DNA virus species from the Nudiviridae, Polyomaviridae, and Herpesviridae, for which few invertebrate viruses have been identified to date.
    [Show full text]
  • Whole-Proteome Phylogeny of Large Dsdna Virus Families by an Alignment-Free Method
    Whole-proteome phylogeny of large dsDNA virus families by an alignment-free method Guohong Albert Wua,b, Se-Ran Juna, Gregory E. Simsa,b, and Sung-Hou Kima,b,1 aDepartment of Chemistry, University of California, Berkeley, CA 94720; and bPhysical Biosciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720 Contributed by Sung-Hou Kim, May 15, 2009 (sent for review February 22, 2009) The vast sequence divergence among different virus groups has self-organizing maps (18) have also been used to understand the presented a great challenge to alignment-based sequence com- grouping of viruses. parison among different virus families. Using an alignment-free In the previous alignment-free phylogenomic studies using l-mer comparison method, we construct the whole-proteome phylogeny profiles, 3 important issues were not properly addressed: (i) the for a population of viruses from 11 viral families comprising 142 selection of the feature length, l, appears to be without logical basis; large dsDNA eukaryote viruses. The method is based on the feature (ii) no statistical assessment of the tree branching support was frequency profiles (FFP), where the length of the feature (l-mer) is provided; and (iii) the effect of HGT on phylogenomic relationship selected to be optimal for phylogenomic inference. We observe was not considered. HGT in LDVs has been documented by that (i) the FFP phylogeny segregates the population into clades, alignment-based methods (19–22), but these studies have mostly the membership of each has remarkable agreement with current searched for HGT from host to a single family of viruses, and there classification by the International Committee on the Taxonomy of has not been a study of interviral family HGT among LDVs.
    [Show full text]
  • Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis
    RESEARCH ARTICLE crossmark Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis Thomas Briese,a,b Amit Kapoor,a,c Nischay Mishra,a Komal Jain,a Arvind Kumar,a Omar J. Jabado,a W. Ian Lipkina,b,c,d Center for Infection and Immunity,a Department of Epidemiology, Mailman School of Public Health,b Department of Pathology and Cell Biology,c and Department of Neurology,d College of Physicians and Surgeons, Columbia University, New York, New York, USA T. Briese and A. Kapoor contributed equally to this work. ABSTRACT Insensitivity and technical complexity have impeded the implementation of high-throughput nucleic acid sequenc- ing in differential diagnosis of viral infections in clinical laboratories. Here, we describe the development of a virome capture sequencing platform for vertebrate viruses (VirCapSeq-VERT) that increases the sensitivity of sequence-based virus detection and characterization. The system uses ~2 million probes that cover the genomes of members of the 207 viral taxa known to infect vertebrates, including humans. A biotinylated oligonucleotide library was synthesized on the NimbleGen cleavable array plat- form and used for solution-based capture of viral nucleic acids present in complex samples containing variable proportions of viral and host nucleic acids. The use of VirCapSeq-VERT resulted in a 100- to 10,000-fold increase in viral reads from blood and tissue homogenates compared to conventional Illumina sequencing using established virus enrichment procedures, including filtration, nuclease treatments, and RiboZero rRNA subtraction. VirCapSeq-VERT had a limit of detection comparable to that of agent-specific real-time PCR in serum, blood, and tissue extracts.
    [Show full text]
  • (EHV-1 and EHV-9): Genetic Diversity, Latency and Co-Infections
    viruses Article Zebra Alphaherpesviruses (EHV-1 and EHV-9): Genetic Diversity, Latency and Co-Infections Azza Abdelgawad 1, Armando Damiani 2, Simon Y. W. Ho 3, Günter Strauss 4, Claudia A. Szentiks 1, Marion L. East 1, Nikolaus Osterrieder 2 and Alex D. Greenwood 1,5,* 1 Leibniz-Institute for Zoo and Wildlife Research, Alfred-Kowalke-Strasse 17, Berlin 10315, Germany; [email protected] (A.A.); [email protected] (C.A.S.); [email protected] (M.L.E.) 2 Institut für Virologie, Freie Universität Berlin, Robert-von-Ostertag-Str. 7-13, Berlin 14163, Germany; [email protected] (A.D.); [email protected] (N.O.) 3 School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia; [email protected] 4 Tierpark Berlin-Friedrichsfelde, Am Tierpark 125, Berlin 10307, Germany; [email protected] 5 Department of Veterinary Medicine, Freie Universität Berlin, Oertzenweg 19, Berlin 14163, Germany * Correspondence: [email protected]; Tel.: +49-30-516-8255 Academic Editor: Joanna Parish Received: 21 July 2016; Accepted: 14 September 2016; Published: 20 September 2016 Abstract: Alphaherpesviruses are highly prevalent in equine populations and co-infections with more than one of these viruses’ strains frequently diagnosed. Lytic replication and latency with subsequent reactivation, along with new episodes of disease, can be influenced by genetic diversity generated by spontaneous mutation and recombination. Latency enhances virus survival by providing an epidemiological strategy for long-term maintenance of divergent strains in animal populations. The alphaherpesviruses equine herpesvirus 1 (EHV-1) and 9 (EHV-9) have recently been shown to cross species barriers, including a recombinant EHV-1 observed in fatal infections of a polar bear and Asian rhinoceros.
    [Show full text]
  • Repurposing the Human Immunodeficiency Virus (Hiv) Integrase
    REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Matthew Robert Pennington August 2018 © 2018 Matthew Robert Pennington REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION Matthew Robert Pennington, Ph.D. Cornell University 2018 Herpesviruses infect many species, inducing a wide range of diseases. Herpesvirus- induced ocular disease, which may lead to blindness, commonly occurs in humans, dogs, and cats, and is caused by human alphaherpesvirus 1 (HHV-1), canid alphaherpesvirus (CHV-1), and felid alphaherpesvirus 1 (FHV-1), respectively. Rapid and effective antiviral therapy is of the utmost importance to control infection in order to preserve the vision of infected people or animals. However, current treatment options are suboptimal, in large part due to the difficulty and cost of de novo drug development and the lack of effective models to bridge work in in vitro cell cultures and in vivo. Repurposing currently approved drugs for viral infections is one strategy to more rapidly identify new therapeutics. Furthermore, studying ocular herpesviruses in cats is of particular importance, as this condition is a frequent disease manifestation in these animals and FHV-1 infection of the cat is increasingly being recognized as a valuable natural- host model of herpesvirus-induced ocular infection First, the current models to study ocular herpesvirus infections were reviewed.
    [Show full text]
  • Commission Directive (Eu)
    L 279/54 EN Offi cial Jour nal of the European Union 31.10.2019 COMMISSION DIRECTIVE (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1), and in particular Article 19 thereof, Whereas: (1) Principle 10 of the European Pillar of Social Rights (2), proclaimed at Gothenburg on 17 November 2017, provides that every worker has the right to a healthy, safe and well-adapted working environment. The workers’ right to a high level of protection of their health and safety at work and to a working environment that is adapted to their professional needs and that enables them to prolong their participation in the labour market includes protection from exposure to biological agents at work. (2) The implementation of the directives related to the health and safety of workers at work, including Directive 2000/54/EC, was the subject of an ex-post evaluation, referred to as a REFIT evaluation. The evaluation looked at the directives’ relevance, at research and at new scientific knowledge in the various fields concerned. The REFIT evaluation, referred to in the Commission Staff Working Document (3), concludes, among other things, that the classified list of biological agents in Annex III to Directive 2000/54/EC needs to be amended in light of scientific and technical progress and that consistency with other relevant directives should be enhanced.
    [Show full text]
  • B Directive 2000/54/Ec of the European
    02000L0054 — EN — 24.06.2020 — 002.001 — 1 This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document ►B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 262, 17.10.2000, p. 21) Amended by: Official Journal No page date ►M1 Commission Directive (EU) 2019/1833 of 24 October 2019 L 279 54 31.10.2019 ►M2 Commission Directive (EU) 2020/739 of 3 June 2020 L 175 11 4.6.2020 02000L0054 — EN — 24.06.2020 — 002.001 — 2 ▼B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) CHAPTER I GENERAL PROVISIONS Article 1 Objective 1. This Directive has as its aim the protection of workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to biological agents at work.
    [Show full text]